Division of Infectious Diseases

Bloch, Haas appointed interim leaders of the Division of Infectious Diseases

Karen Bloch, MD, MPH, and David Haas, MD, have been appointed interim leaders of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center.

Antimicrobial stewardship effort expanding reach

The Vanderbilt Antimicrobial Stewardship Program recently expanded to the outpatient realm to provide more support for providers to optimize antibiotic use and delivery in the clinic setting.

Who’s who in the respiratory landscape

A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.

Wanjalla honored by Doris Duke Foundation

Celestine Wanjalla, MD, PhD, assistant professor of Medicine in the Division of Infectious Diseases, is among 17 recipients of the Doris Duke Charitable Foundation 2021 Clinical Scientist Development Award.

Certain drug exposures correlate with reduced COVID severity: study

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.

Aronoff departing VUMC to become chair of the Department of Medicine at Indiana University School of Medicine

David Aronoff, MD, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases, is departing Vanderbilt University Medical Center to become chair of the Department of Medicine at Indiana University School of Medicine.

1 3 4 5 6 7 13